Tuesday, May 3, 2011

Supply Chain Failure 1: Medicine

We will have a second part to this type of supply chain problem.  Our subject for the moment is prescription medications, which in the United States where increasingly any one type of drugs is often only sourced from one provider.
A secondary issue of this concentration, is that it makes regulators job much more difficult because if they try and stop eggregious practises they risk the entire product chain collapsing.
Rob Stein, Washington Post, 26 April 2011
A record 211 medications became scarce in 2010 — triple the number in 2006 — and at least 89 new shortages have been recorded through the end of March, putting the nation on track for far more scarcities.
The paucities are forcing some medical centers to ration drugs — including one urgently needed by leukemia patients — postpone surgeries and other care, and scramble for substitutes, often resorting to alternatives that may be less effective, have more side effects and boost the risk for overdoses and other sometimes-fatal errors.
The causes vary from drug to drug, but experts cite a confluence of factors: Consolidation in the pharmaceutical industry has left only a few manufacturers for many older, less profitable products, meaning that when raw material runs short, equipment breaks down or government regulators crack down, the snags can quickly spiral into shortages...
“The types of products we’re seeing shortages of are really concerning,” said Valerie Jensen, who heads the FDA’s Drug Shortages Program. “This is affecting oncology drugs, critical-care drugs, emergency medicine drugs. We’re doing everything we can under our current authority to try to deal with this situation.”

No comments: